NeoGenomics Q2 Revenues up 18 Percent as Firm Beats Analyst Estimates
The firm said that both its test volume and average revenue per test were up year over year, with 295,116 tests performed during the quarter.
Source: genomeweb.com
Moldx Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Moldx Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Moldx Program Today - Breaking & Trending Today
VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients
25.07.2023 - - Blood-based test differentiates between ABMR and IgAN, enabling faster and more effective treatment- Improved utility over standard of care tests- Paper published in peer-reviewed journal IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) - ... Seite 1
Source: wallstreet-online.de
Lucid Diagnostics Reports Publication of Future Effective Foundational Local Coverage Determination by Medicare Administrative Contractor Noridian Healthcare Solutions
/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid Diagnostics" or "Lucid"), a commercial-stage cancer prevention diagnostics company and a...
Source: prnewswire.com
PAVMED INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Item 7.01. Regulation FD Disclosure. On March 31, 2023, Lucid Diagnostics Inc. , a majority owned subsidiary of PAVmed Inc. , issued a press release announcing that, on March 30, 2023, the MolDX... | April 3, 2023
Source: marketscreener.com